JPS60224636A - Production of antibody of high quality - Google Patents

Production of antibody of high quality

Info

Publication number
JPS60224636A
JPS60224636A JP8063184A JP8063184A JPS60224636A JP S60224636 A JPS60224636 A JP S60224636A JP 8063184 A JP8063184 A JP 8063184A JP 8063184 A JP8063184 A JP 8063184A JP S60224636 A JPS60224636 A JP S60224636A
Authority
JP
Japan
Prior art keywords
antibody
raw material
specificity
antibodies
affinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8063184A
Other languages
Japanese (ja)
Inventor
Kiyoshi Miyai
宮井 潔
Yuichi Endo
雄一 遠藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP8063184A priority Critical patent/JPS60224636A/en
Publication of JPS60224636A publication Critical patent/JPS60224636A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain an antibody of high quality having higher affinity and specificity than those of a raw material antibody which is a polyclonal antibody, by isoelectric focusing of the raw material antibody. CONSTITUTION:A raw material antibody collected by giving an antigen to immunize an animal is subjected to isoelectric focusing to afford the aimed antibody having higher affinity and specificity than those of the raw material antibody which is not a simple antibody but an aggregate of many immunoglobulins having various specificities and affinities. So far as the raw material antibody is used as a mixture, averaged rather low specificity and affinity are produced. The isoelectric focusing is carried out by dispersing various amphoteric carriers having individual isoelectric points in a floating field, placing a spot of the raw material antibody at an optional point, applying electric charge thereto, moving the above-mentioned antibody to the positions of the respective intrinsic isoelectric points, and separating the antibody as a mixture or simple substance having the isoelectric points as a common factor. The simple substance exhibits higher affinity and specificity than those of the raw material antibody.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は等電点電気泳動の技法を利用することによル多
りローン性抗体から高品質抗体を採取する方法に関する
ものである。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a method for collecting high quality antibodies from a large number of cloned antibodies by utilizing the technique of isoelectric focusing.

〔従来の技術〕[Conventional technology]

抗原が与えられた動物は免疫を獲得し、その動物から採
取される抗血清中には前記抗原と特異的に反応する抗体
が含まれる。しかしこの抗体は単一の抗体ではなく、色
々な特異性並びに親和性を有する多数の免疫グロブリン
(以下Igと表記する)の集合体であることがわかって
おシ、一般に多クローン性抗体と呼んでいる。即ち多ク
ローン性抗体は特異性乃至親和性の異なる色々な単クロ
ーン性抗体の集合体であると言うことができる。
An animal given an antigen acquires immunity, and the antiserum collected from the animal contains antibodies that specifically react with the antigen. However, this antibody is not a single antibody, but a collection of many immunoglobulins (hereinafter referred to as Ig) with various specificities and affinities, and is generally called a polyclonal antibody. I'm here. In other words, polyclonal antibodies can be said to be a collection of various monoclonal antibodies with different specificities and affinities.

一方抗原抗体反応(免疫学的反応)の特異性は生体内だ
けでなく試験管内でも再現されるので、例えば色々な物
質(抗原)が混在している標品の中から、目標とする抗
原を検出、同定或は定量する場合にはこの抗原抗体反応
を利用することが行なわれている。したがって抗原抗体
反応を応用して分析しようとすれば特異性の高い、又親
和性の高い高品質の抗体を使用することが望ましく特異
性や親和性の良否が成績の良し悪しを決定すると言われ
ている。
On the other hand, the specificity of antigen-antibody reactions (immunological reactions) can be reproduced not only in vivo but also in vitro, so for example, it is possible to identify a target antigen from a specimen containing a mixture of various substances (antigens). This antigen-antibody reaction is used for detection, identification, or quantification. Therefore, if you are going to apply an antigen-antibody reaction for analysis, it is desirable to use high-quality antibodies with high specificity and high affinity.It is said that the quality of specificity and affinity determines the quality of the results. ing.

しかしながら前に述べた如く抗血清中の抗体は多クロー
ン性抗体であシ、特異性や親和性の高い抗体と特異性や
親和性の低い抗体が混合しているから、これらを混合物
として使用する限シ、平均化された低めの特異性や親和
性が発現されるに過ぎない。そこで■免疫注射に用いる
抗原として十分に精製されたものを使用する、■免疫注
射動物として適当なものを選択する、■免疫注射法を工
夫する等によって高品質の抗血清を得る様に努力されて
いる。そしてこのような方法によシある程度力価や特異
性・親和性の高いものが得られることもあるが、その結
果は一定せず、動物の個体差などの理由によシ、必ずし
もこのような高品質抗体が得られるとは限らない。
However, as mentioned earlier, the antibodies in antiserum are polyclonal antibodies, and are a mixture of antibodies with high specificity and affinity and antibodies with low specificity and affinity, so these should be used as a mixture. Only a limited, averaged and lower specificity or affinity is expressed. Therefore, efforts have been made to obtain high-quality antisera by: ■ using sufficiently purified antigens for immunization injections, ■ selecting appropriate antigens for immunization injection animals, and ■ devising immunization injection methods. ing. Although these methods can sometimes yield products with high potency, specificity, and affinity, the results are not consistent and may vary due to individual differences among animals. It is not always possible to obtain high quality antibodies.

この様なところから、実際に得られている多クローン性
抗体を原料とし、抗体に結合している内在性の抗原を除
去することによって親和性を向上させようという手段、
更には細砲融合法によって特異性の高い単り胃−ン性抗
体を取出す方法等が検討されている。しかし前者の方法
では必ずしも溝足のいく結果が得られるとは限らず、又
後者の方法では極めて多数の生細胞を取扱わなければな
らないという煩雑さに加えて1つ1つを個々にスクリー
ニングするという手間が必要であシ、しかもそうすると
とKよってようやく得られる単クローン性抗体は、多く
の場合却って親和性が低くなっているというのが実情で
ある。
From this point of view, a method of improving affinity by using actually obtained polyclonal antibodies as raw materials and removing endogenous antigens bound to the antibodies,
Furthermore, a method of extracting highly specific monogenic antibodies using the gun fusion method is being studied. However, the former method does not necessarily yield consistent results, and the latter method requires the complexity of handling a large number of living cells, as well as the need to screen each one individually. However, the fact is that the monoclonal antibodies that are finally obtained by this process often have low affinity.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

本発明者等はこの様な状況を憂慮し、一般的手法に基づ
いて得られる多クローン性抗体を原料とし、その原料抗
体の中から特異性や親和性(特に親和性)の優れた単ク
ローン性抗体を取出す方法について検討を開始した。特
に本発明者等はIgを構成するアミノ酸組成やアミノ酸
配列が夫々の単クローン性抗体によって個々に少しずつ
相違すること、並びにこの相違によって各抗体に夫々個
有の等電点(pI)が存在することに注目し、等電点の
相違を利用すれば多クローン性抗体が細かく分離され、
しかも分離されたものが等電点を共通因子として単体又
は混合物として採取されることによシ、抗体としての化
学的特性、殊に親和性や特異性について特異な性状を有
することになるのではないかと考え、多数の基礎実験を
繰返し、鼓に本発明を完成するに至った。
Concerned about this situation, the present inventors used polyclonal antibodies obtained based on general methods as raw materials, and selected monoclones with excellent specificity and affinity (especially affinity) from among the raw antibodies. We have started investigating methods for extracting sexual antibodies. In particular, the present inventors have discovered that the amino acid composition and amino acid sequence constituting Ig differ slightly depending on each monoclonal antibody, and that due to these differences, each antibody has its own unique isoelectric point (pI). By focusing on the fact that
Moreover, because the separated substances are collected singly or as a mixture with the isoelectric point as a common factor, they may have unique chemical properties as antibodies, especially in terms of affinity and specificity. After many basic experiments, they finally completed the invention.

〔問題点を解決する為の手段〕[Means for solving problems]

本発明の要旨は、抗原を動物に与えて免疫することKよ
〕採取される多クローン性の抗体を原料とし、これを等
電点電気泳動に付すことによシ、原料抗体よシも高親和
性や高特異性特性を示す両分の抗体を採取する点に存在
する。
The gist of the present invention is to give an antigen to an animal for immunization.The collected polyclonal antibody is used as a raw material, and by subjecting it to isoelectric focusing, the raw material antibody can also be immunized. It exists in the collection of both types of antibodies that exhibit high affinity and high specificity characteristics.

〔作用〕[Effect]

等電点電気泳動法とは、電荷がかけられるべき泳動場に
、夫々個有の等電点を持っている色々な両性担体を分散
させておき、泳動場の任意の点に原料である多クローン
性抗体のスポットを置いて電荷をかける方法であって、
前記両性担体が夫々の等電点に応じて異なったpHを示
すことにより電位差方向に沿ってpH勾配が形成される
ことになる。従ってスポットされた原料抗体中の各単り
四−ン性抗体は、夫々個有の等電点位置に向けて移動す
るととKなシ、等電点を共通因子とする混合物又は単体
として分離される。従って電気化学的特性によって分離
された混合物又は単体は、抗体としての化学的特性、殊
に親和性や特異性について夫々の特性を発揮するに至る
Isoelectric focusing is a method in which various amphoteric carriers, each with its own isoelectric point, are dispersed in the electrophoresis field to which a charge is to be applied, and the raw material polyamide is placed at any point in the electrophoresis field. A method of placing a spot of clonal antibody and applying a charge,
Since the amphoteric carriers exhibit different pH values depending on their respective isoelectric points, a pH gradient is formed along the direction of potential difference. Therefore, when each mono-quaternary antibody in the spotted raw material antibody moves toward its unique isoelectric point position, it is separated as a mixture or a single substance with the isoelectric point as a common factor. Ru. Therefore, mixtures or single substances separated by electrochemical properties exhibit their respective chemical properties as antibodies, particularly in terms of affinity and specificity.

尚本発明の等電点電気泳動に用いられる支持体としては
、ポリアクリルアミドゲル、アガロースゲル、セファデ
ックスゲル等が挙げられるが勿論これに限定されるべき
理由はなく、この他泳動場の構成2両性担体の種類や数
、或は電場の形成手段等についても一切の制限は受けな
い。
Supports used in the isoelectric focusing of the present invention include polyacrylamide gels, agarose gels, Sephadex gels, etc., but of course there is no reason to limit them to these. There are no restrictions on the type or number of amphoteric carriers or the means for forming an electric field.

又本発明が適用される原料抗体についても全く制限され
ず、どの様な抗原をどの様な動物に対しどの様に与えて
免疫したかということIc左右されず、多クローン性抗
体であれば全て本発明に利用できる。もつとも分離の様
相は抗体によって多少相違し、特に親和性の高い抗体が
得られる場合や親和性のみならず特異性においても優れ
て高い抗体が得られる場合もある。例えばヒト甲状腺刺
激ホルモン(hTSH)を家兎に免疫して得た抗血清(
hTsH抗血清)の免疫グロブリンG (IgG)分画
を、アガロースゲルを支持体とする等電点電気泳動法(
IEF)で分離すると20種類以上のタンパクバンドに
分けることができ、その一部は高特異性・高親和性の抗
hTSH抗体である。尚この例における分離の機構につ
いて研究したところによると、(1)IgGのペプシン
処理によって得たFc7ラグメントは、アガロースゲル
IEFによ、9pH;7.0〜7.3の間で2つのタン
パクバンドに分けられたに過ぎなかったが、(2)同じ
様にして得たF (a b’)1フラグメイト(抗原結
合部位を含ム)でh、p I:5〜90間で多くのタン
パクバンドに分離しておシ、(1) 、 (2)の結果
を総合すると、多クローン性の家兎IgGのIEFによ
る分離は、F (a b’)17;7グメントのpIに
基づくものであるとの結論を下すことができる。
Furthermore, the raw material antibodies to which the present invention is applied are not limited at all, and it does not depend on what kind of antigen is given to what kind of animal and how it is immunized, and any polyclonal antibody can be used. It can be used in the present invention. However, the manner of separation differs somewhat depending on the antibody, and there are cases in which an antibody with particularly high affinity is obtained, and there are cases in which an antibody with excellent not only affinity but also high specificity is obtained. For example, antiserum obtained by immunizing a rabbit with human thyroid stimulating hormone (hTSH) (
The immunoglobulin G (IgG) fraction of hTsH antiserum was subjected to isoelectric focusing using an agarose gel as a support.
When separated using IEF), it can be divided into more than 20 types of protein bands, some of which are highly specific and high affinity anti-hTSH antibodies. According to research on the separation mechanism in this example, (1) the Fc7 fragment obtained by pepsin treatment of IgG was separated into two protein bands by agarose gel IEF at 9 pH; between 7.0 and 7.3. (2) The F (a b')1 fragment (containing the antigen-binding site) obtained in the same manner was found to contain many proteins with h, p I: between 5 and 90. Combining the results of (1) and (2), the separation of polyclonal rabbit IgG by IEF is based on the pI of the F(ab')17;7 segment. It can be concluded that there is.

いずれにせよ本発明ではこの様に分離されたタンパクバ
ンドの中から、特に高親和性あるいは高特異性の抗体を
採取すれば良い。
In any case, in the present invention, antibodies with particularly high affinity or high specificity may be collected from the protein bands thus separated.

〔実施例〕〔Example〕

実施例1 高特異性・高親和性抗hTSH抗体の分離■方法 抗hTsH家兎血清を用い常法に従った硫酸ナトリウム
による塩析およびジエチルアミンエチルセルロースを用
いたり四マドグラフィを行なうことによシIgG分画を
調製した(抗hTSHIgG)、以下等電点電気泳動に
かけたが、※印はファルマシア社製のものを用いたこと
を示す。pH3〜10と5〜8の範囲でファルマライト
(Pharmalyte)を含むアガロースゲルプレー
)(12X12cm)を作製した。電極溶液は陰極側を
IN水酸化ナトリウム水溶液とし、陽極側を0.05M
硫酸とした。
Example 1 Isolation of highly specific and high affinity anti-hTSH antibodies ■ Method Using anti-hTsH rabbit serum, IgG was isolated by salting out with sodium sulfate and diethylamine ethylcellulose, or by performing four-mardography. A sample was prepared (anti-hTSHIgG) and subjected to isoelectric focusing below, and the asterisk (*) indicates that a product manufactured by Pharmacia was used. Agarose gel sprays (12×12 cm) containing Pharmalyte at pH ranges of 3-10 and 5-8 were prepared. The electrode solution is IN sodium hydroxide aqueous solution on the cathode side and 0.05M on the anode side.
It was made into sulfuric acid.

アガロースゲルプレートをフラットベッド電気泳動装置
(FBE−3000/150町に入れ、定電圧装置(E
CPS−3000/150W′)を用い冷却下8Wで0
.7KVに到達するまで通電した。8mM塩化ナトリウ
ム水溶液に透析後の抗hTsHIgG(10〜20μl
)を陰極側から3〜4cmの位置で濾紙上にスポットし
た(タンパク染色用には0.1〜0.2岬のIgGを2
枚の濾紙に、またIEF分離後の回収用にUo、4〜1
1ngのIgGを4〜5枚の濾紙に添加した)。まず1
.5 K Vの電圧が得られるまで8Wで約60分間通
電し、さらに1.5KVで30〜60分通電した。その
後、プラスチックゲルプレートを2分割し、その一方を
タンノ(り染色に用い、他方を抗体の回収に用いた。タ
ンパク染色に際しては、まず工Oq6トリクロロ酢酸と
5チスルホ、サリチル酸を含むタンパク固定液に30分
間浸し、タンパクをゲル内に固定し、次いで1゜チ酢醸
を含む30%エタノール液で洗浄してから0.2チクマ
シーブリリアントブルーRで染色した。
Place the agarose gel plate in a flatbed electrophoresis device (FBE-3000/150), and place it in a constant voltage device (E
CPS-3000/150W') at 8W under cooling.
.. Electricity was applied until it reached 7KV. Anti-hTsHIgG (10-20μl) after dialysis against 8mM sodium chloride aqueous solution
) was spotted on the filter paper at a position 3 to 4 cm from the cathode side (for protein staining, 0.1 to 0.2 caps of IgG was spotted at 2 cm from the cathode side).
Uo, 4-1 for recovery after IEF separation.
1 ng of IgG was added to 4-5 filter papers). First 1
.. A current of 8 W was applied for about 60 minutes until a voltage of 5 KV was obtained, and then a current of 1.5 KV was applied for 30 to 60 minutes. After that, the plastic gel plate was divided into two parts, and one part was used for tanno(reactive staining) and the other part was used for antibody recovery.For protein staining, first, the plastic gel plate was divided into two parts, and the other part was used for antibody recovery. The proteins were fixed in the gel by soaking for 30 minutes, and then washed with a 30% ethanol solution containing 1° vinegar and stained with 0.2 ml Brilliant Blue R.

一方ゲルからの抗体の回収鉱、抗体回収用に分割したプ
レート上のゲルを2mm巾に切シ、各細片を試験管に移
し、0.1%ウシ血清アルブミンと0.1%NaN6を
含む0.1Mリン酸緩衝液、pH8,0(緩衝液T)を
1−加え4℃で一昼夜以上放置することによシ行った。
Meanwhile, for antibody recovery from the gel, cut the gel on the divided plate into 2 mm width pieces, transfer each piece to a test tube containing 0.1% bovine serum albumin and 0.1% NaN6. This was carried out by adding 0.1 M phosphate buffer, pH 8.0 (buffer T), and leaving the mixture at 4° C. for over a day and night.

その後抽出液を回収し、抗体価、hTsHに対する結合
親和性および特異性′をラジオイムノアッセイ(RIA
)を用いて調べた。ゲル上のpH勾配と分離した抗体分
子のpI性、同様にして泳動したpI測定用キットの標
準タンパクyの移動度からめた。抗体価および結合親和
性を測定するためのRIAにおいては、まずIEF分離
前後の各抗体分画を種々の濃度の非標識hTSHの存在
下(もしくは非存在下)で、約8nCIの””I−hT
SHと、最終液量300plの緩衝液T中でインキュベ
ートした。ここで用いた抗体量は I−hTSHの抗体
結合量が約50%になるように調整した。この条件下で
室温20時間インキュベートしたのち、4μlの正常家
兎血清と至適量の抗家兎1gG山羊血清を加えて塞温で
一昼夜再びインキュベート後、2000gで15分間遠
心分離し、沈渣をr−カウンターで計測した。結合親和
定数は5catchard プロットによる解析で算出
した。hTSHに対する結合親和性はヒト胎盤性ゴナド
トロピン(hCG)の過剰量(1、I X 10−”M
)存在下においても同様にして測定した。hTSHに対
する抗体の特異性はhCGに対する交叉反応性を指標と
して検討した。すなわち、各抗体分画を種々濃度のhC
Gの存在下で1251−hTSHとインキュベートし、
hCGによるhTSHの置換の程度を同様のRIA法に
より測定した。
The extract was then collected, and the antibody titer, binding affinity and specificity for hTsH were determined by radioimmunoassay (RIA).
). This was determined from the pH gradient on the gel, the pI property of the separated antibody molecules, and the mobility of the standard protein y from the pI measurement kit, which was electrophoresed in the same manner. In RIA for measuring antibody titer and binding affinity, first, each antibody fraction before and after IEF separation is subjected to approximately 8 nCI of "I-" in the presence (or absence) of various concentrations of unlabeled hTSH. hT
SH and incubated in buffer T in a final volume of 300 pl. The amount of antibody used here was adjusted so that the amount of antibody binding to I-hTSH was approximately 50%. After incubating under these conditions at room temperature for 20 hours, 4 μl of normal rabbit serum and an optimal amount of anti-rabbit 1gG goat serum were added, and the mixture was incubated again overnight in an incubation state, centrifuged at 2000 g for 15 minutes, and the precipitate was collected by r- Measured with a counter. The binding affinity constant was calculated by analysis using 5catchard plot. The binding affinity for hTSH was determined by the excess amount of human placental gonadotropin (hCG) (1, I
) Measurements were made in the same manner in the presence of The specificity of the antibody to hTSH was examined using cross-reactivity to hCG as an index. That is, each antibody fraction was treated with various concentrations of hC.
incubating with 1251-hTSH in the presence of G;
The extent of replacement of hTSH by hCG was determined by a similar RIA method.

■成績 pH3〜10および5〜8の範囲でIEFによつて分離
された各抗体分画のpI、hCGとの交叉性、hTSH
との結合親和性を第1表に示した。
■Results pI of each antibody fraction separated by IEF in the pH range of 3-10 and 5-8, cross-reactivity with hCG, hTSH
The binding affinity with is shown in Table 1.

pH3〜10の範囲でIEFを行った場合、plの低下
とほぼ平行してhCGに対する交叉性の少ない、すなわ
ち特異性の高い抗体が得られた。またpH5〜8の範囲
でIEFを行った場合も交叉性に関しては同様の結果を
得たが、分画番号11および21から得た抗体は、はと
んど交叉反応を示さなかった(交叉反応率は原血清の約
2分の1)。
When IEF was performed in the pH range of 3 to 10, an antibody with less cross-reactivity to hCG, that is, with high specificity, was obtained almost in parallel with the decrease in pl. Similar results regarding cross-reactivity were also obtained when IEF was performed in the pH range of 5 to 8, but antibodies obtained from fraction numbers 11 and 21 rarely showed cross-reactivity (cross-reactivity The rate is approximately 1/2 that of the original serum).

また分画番号13の結合親和定数はhCG非存在下で原
血清の約2倍であった。
Furthermore, the binding affinity constant of fraction number 13 was approximately twice that of the original serum in the absence of hCG.

実施例2 高親相性抗サイロキシン(T4 )抗体の分離■方法 抗T4家兎血清からのIgG分画の調製およびIgG分
画のアガロースIEFによる分離回収は抗hTSH抗体
の場合と同様に行った。ただし、アガロースゲル細片か
らの抗体の抽出には40μg〜の8−アニリノ−1−ナ
フタレン硫酸および1.67ay/ゴのサリチル酸を含
む20mM)リス塩酸緩衝液、pH9,0(緩衝液R)
を用いた。
Example 2 Isolation of highly affinity anti-thyroxine (T4) antibody Method Preparation of an IgG fraction from anti-T4 rabbit serum and separation and recovery of the IgG fraction using agarose IEF were carried out in the same manner as for the anti-hTSH antibody. However, for extraction of antibodies from agarose gel strips, 20mM) Lis-HCl buffer containing ~40μg of 8-anilino-1-naphthalene sulfate and 1.67ay/g of salicylic acid, pH 9.0 (Buffer R), is used.
was used.

抗体価および結合親和性を測定するRIAにおいては、
各抗体分画を300μノの緩衝液R中で約8 nci 
(D 126I −74とインキュベートした。室温で
約20時間のインキュベート後の操作および解析は抗h
TSH抗体の場合と同様に行った。
In RIA, which measures antibody titer and binding affinity,
Each antibody fraction was incubated at approximately 8 nci in 300 μm of Buffer R.
(Incubated with D 126I-74. After approximately 20 hours of incubation at room temperature, manipulation and analysis were carried out with anti-h
The same procedure as for the TSH antibody was carried out.

■成績 pH3〜10の範囲のIEFによシ分画された抗体のT
、に対する結合親和定数は(1,8X 10”) 1 〜(8,3X10’ ) M の範囲にあった。このう
ちの最も高い値は、原血清(IgG分画)の結合親和定
数Z、2 x 10’ M−’ に比較し、3〜4倍高
かった。この高親和性抗体を用い九T4測定のためのR
IAにおいては、3〜5倍高い測定感度が得られた。
■Results T of antibodies fractionated by IEF in the pH range of 3 to 10
The binding affinity constant for , was in the range of (1,8X 10'') 1 to (8,3X10') M. The highest value among these was the binding affinity constant Z, 2 of the raw serum (IgG fraction). x 10'M-'.
In IA, a measurement sensitivity 3 to 5 times higher was obtained.

〔発明の効果〕〔Effect of the invention〕

本発明は上記の様に構成されているので、常法によって
得られる多クローン性抗体を原料とし、比較的簡単匁手
法によって原料抗体に比べ特に親和性や特異性の高い高
品質抗体を製造することが可能となった。
Since the present invention is configured as described above, a polyclonal antibody obtained by a conventional method is used as a raw material, and a high-quality antibody with particularly high affinity and specificity compared to the raw material antibody is produced by a relatively simple method. It became possible.

Claims (1)

【特許請求の範囲】[Claims] 抗原を動物に与えて免疫することによ)採取される原料
抗体を、等電点電気泳動に付すことによシ、原料抗体よ
)親和性や特異性の高い抗体を採取することを特徴とす
る高品質抗体を製造する方法。
It is characterized by collecting raw antibodies (by giving antigen to animals for immunization) and subjecting them to isoelectric focusing to collect antibodies with high affinity and specificity (as compared to raw antibodies). A method for producing high-quality antibodies.
JP8063184A 1984-04-21 1984-04-21 Production of antibody of high quality Pending JPS60224636A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8063184A JPS60224636A (en) 1984-04-21 1984-04-21 Production of antibody of high quality

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8063184A JPS60224636A (en) 1984-04-21 1984-04-21 Production of antibody of high quality

Publications (1)

Publication Number Publication Date
JPS60224636A true JPS60224636A (en) 1985-11-09

Family

ID=13723704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8063184A Pending JPS60224636A (en) 1984-04-21 1984-04-21 Production of antibody of high quality

Country Status (1)

Country Link
JP (1) JPS60224636A (en)

Similar Documents

Publication Publication Date Title
Edelman et al. Immunological studies of human γ-globulin: Relation of the precipitin lines of whole γ-globulin to those of the fragments produced by papain
EP0158746B1 (en) Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays
CA1210345A (en) A.t.c.c.hb8209 and its monoclonal antibody to erythropoietin
RU94045249A (en) Monomeric antibody, method of antibody preparing, dimeric fused protein, method of protein preparing, set of structures
CN110272502B (en) Immunogen, hybridoma cell secreting anti-cardiac troponin I monoclonal antibody, preparation method, monoclonal antibody and application
US6410692B2 (en) Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix
AU632535B2 (en) Cancer related haptoglobin (hpr)
US5187063A (en) Measuring non-dystrophin proteins and diagnosing muscular dystrophy
EP0244473A1 (en) Method of assaying the presence of cancer cells
JP4926114B2 (en) Search for cancer markers by a novel screening method
JP2008239511A (en) Monoclonal antibody, kit for determination of equine saa and method for diagnosis of equine inflammatory disease
DE69629976T2 (en) Type I procollagen amino terminal propeptide, its antibody and test method using it
CN113845592B (en) anti-CK 5/6 protein monoclonal antibody, cell strain thereof, preparation method and application
DE68929511T2 (en) Detection, quantification and classification of RAS proteins in body fluids and tissues
US5430129A (en) Purified, native dystrophin
JPS60224636A (en) Production of antibody of high quality
EP1796723B1 (en) Method of diagnosing cancer by detecting the expression of spag9 or the presence of anti-spag9 antibodies
DE3633323A1 (en) NEW MONOCLONAL ANTIBODIES AGAINST IFN-OMEGA, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR CLEANING AND DETECTING IFN-OMEGA
JPH07110879B2 (en) Monoclonal antibody
JP2009508087A (en) Monoclonal antibody reagent
JPH04252195A (en) Monoclonal antibody and hybridoma
JP4527286B2 (en) Method for quantifying the total amount of S100αβ and S100ββ in a sample, method for quantifying the amount of S100ββ in a sample, method for quantifying the amount of S100αβ in a sample, kit for assaying the amount of S100ββ, assaying the amount of S100αβ Kits, hybridoma cell line S10: 3, hybridoma cell line S35: 2, and hybridoma cell line S23: 2
WO1999039204A1 (en) Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix
JPH0677017B2 (en) A method for the immunoassay of human dehydrogenase type IV collagen
JP5448424B2 (en) Reagent for measuring protein containing Fc of human IgG